These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10741260)

  • 1. [Gamma-interferon in patients with uveal melanoma].
    Likhvantseva VG; Slepova OS; Brovkina AF
    Vestn Oftalmol; 2000; 116(1):26-8. PubMed ID: 10741260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon status of patients with uveal melanoma].
    Likhvantseva VG; Slepova OS; Brovkina AF
    Vestn Oftalmol; 1999; 115(6):35-7. PubMed ID: 10665288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-6 in patients with uveal melanoma].
    Likhvantseva VG; Slepova OS; Gerasimenko VA
    Vestn Oftalmol; 1997; 113(5):39-41. PubMed ID: 9508749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
    Anurova OA; Likhvantseva VG; Vereshchagina MV
    Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical assessment of mitotic count in uveal melanoma.
    Angi M; Damato B; Kalirai H; Dodson A; Taktak A; Coupland SE
    Acta Ophthalmol; 2011 Mar; 89(2):e155-60. PubMed ID: 19900200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

  • 8. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin-D1 in uveal malignant melanoma.
    Errico ME; Staibano S; Tranfa F; Bonavolonta G; Lo Muzio L; Somma P; Lucariello A; Mansueto G; D'Aponte A; Ferrara G; De Rosa G
    Anticancer Res; 2003; 23(3B):2701-6. PubMed ID: 12894561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor: risk factor in uveal melanoma.
    Hurks HM; Metzelaar-Blok JA; Barthen ER; Zwinderman AH; De Wolff-Rouendaal D; Keunen JE; Jager MJ
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2023-7. PubMed ID: 10892838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
    Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
    Ben Simon GJ; Abulafia A; Pe'er J
    Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
    Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A; Talan-Hranilović J; Belicza M
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse pigmentation mutants help identify a uveal melanoma oncogene.
    Hayward NK
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):2-3. PubMed ID: 19140886
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
    Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-knife-based stereotactic radiosurgery for uveal melanoma.
    Fakiris AJ; Lo SS; Henderson MA; Witt TC; Worth RM; Danis RP; Des Rosiers PM; Timmerman RD
    Stereotact Funct Neurosurg; 2007; 85(2-3):106-12. PubMed ID: 17228176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.